Prostatectomy data suggest that a substantial proportion have higher-grade disease; 30%–
50% of patients undergo treatment in the first 5 years despite< 3% 15-to 20-year mortality; …

We aimed to review the current state‐of‐the‐art imaging methods used for primary and
secondary staging of prostate cancer, mainly focusing on multiparametric magnetic …

Despite recent improvements in detection and treatment, prostate cancer continues to be the
most common malignancy and the second leading cause of cancer-related mortality. Thus …

Prostate cancer is the most common malignancy in males. Men aged 50 years and older are
recommended to undergo an annual digital rectal examination (DRE) and determination of …

Recent developments in (molecular) imaging technologies have led to significant changes
in diagnostic, staging, and therapeutic processes in prostate cancer (PCa). The recent …

OBJECTIVE. This article reviews a recent 2-day workshop on prostate cancer and imaging
technology that was conducted by the Cancer Imaging Program of the National Cancer …

Prostate cancer is the most common malignancy in men, in general. Most patients
diagnosed with prostate cancer have localized disease confined to the prostate. A small …

Prostate cancer (PCa) is the most common noncutaneous malignancy in men and the
second leading cause of cancer related death in the United States. Men with clinical …

The clinical management of prostate cancer continues to be one of the most controversial
areas in medicine, with no consensus on the need for cancer screening, choice of diagnostic …

Accurate tumor detection and establishment of disease extent are important for optimal
management of prostate cancer. Disease stage, beginning with identification of the index …